EPAS1 and colorectal carcinoma: Overall, 81% (n = 35/43) of CRC having associated adenoma exhibited high EPAS1 mRNA expression, whereas 59% (n = 23/39) of CRC having no associated adenoma had high EPAS1 mRNA expression (p = 0.02).